Klonoff-Cohen H, Lam-Kruglick P
Department of Family and Preventive Medicine, Division of Epidemiology, University of California, San Diego, 9500 Gilman Dr, 0607, La Jolla, CA 92093-0607, USA.
Arch Pediatr Adolesc Med. 2001 Jul;155(7):765-70. doi: 10.1001/archpedi.155.7.765.
To determine whether maternal or paternal use of cocaine, opiates, or marijuana during conception and pregnancy and postnatally increases the risk of sudden infant death syndrome (SIDS) during the first year of the infant's life. This is an important issue and may prove useful in further decreasing the rate of SIDS.
A case-control study was conducted consisting of 239 infants who died of SIDS in southern California between 1989 and 1992, and 239 healthy infants who were matched on the basis of birth hospital, date of birth, age, and sex. Specific drug use at the period of conception, during pregnancy and breastfeeding, and in the presence or vicinity of the infant was ascertained by telephone for the white, African American, Hispanic, Asian American, and Pacific Islander case and control fathers and mothers.
Maternal recreational drug use during pregnancy was not associated with the risk of SIDS after adjusting for maternal smoking during pregnancy (adjusted odds ratio [OR] = 2.0; 95% confidence interval [CI], 0.6-6.5). There were statistically significant differences between case and control fathers' use of marijuana during conception (OR = 2.2; 95% CI, 1.2-4.2; P =.01), during pregnancy (OR = 2.0; 95% CI, 1.0-4.1; P =.05), and postnatally (OR = 2.8; 95% CI, 1.1-7.3; P =.04) and the risk of SIDS, while adjusting for paternal smoking and alcohol use.
There was no association between maternal recreational drug use and SIDS. Paternal marijuana use during the periods of conception and pregnancy and postnatally were significantly associated with SIDS. The role of paternal psychoactive drug use, especially the relationship between marijuana and SIDS, is an understudied area; however, before any definitive role for the father can be confirmed, these findings should be investigated and replicated in future studies.
确定母亲或父亲在受孕、孕期及产后使用可卡因、阿片类药物或大麻是否会增加婴儿出生后第一年发生婴儿猝死综合征(SIDS)的风险。这是一个重要问题,可能对进一步降低SIDS发生率有用。
进行了一项病例对照研究,研究对象包括1989年至1992年间在南加州死于SIDS的239名婴儿,以及239名在出生医院、出生日期、年龄和性别方面相匹配的健康婴儿。通过电话询问白人、非裔美国人、西班牙裔、亚裔美国人和太平洋岛民病例组和对照组的父母在受孕期间、孕期和哺乳期以及婴儿在场或附近时的特定药物使用情况。
在对孕期母亲吸烟情况进行校正后,孕期母亲使用消遣性药物与SIDS风险无关(校正比值比[OR]=2.0;95%置信区间[CI],0.6-6.5)。在对父亲吸烟和饮酒情况进行校正后,病例组和对照组父亲在受孕期间(OR=2.2;95%CI,1.2-4.2;P=0.01)、孕期(OR=2.0;95%CI,1.0-4.1;P=0.05)和产后(OR=2.8;95%CI,1.1-7.3;P=0.04)使用大麻与SIDS风险之间存在统计学显著差异。
母亲使用消遣性药物与SIDS之间无关联。父亲在受孕、孕期及产后使用大麻与SIDS显著相关。父亲使用精神活性药物的作用,尤其是大麻与SIDS之间的关系,是一个研究较少的领域;然而,在确定父亲的任何明确作用之前,这些发现应在未来研究中进行调查和重复验证。